• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过原位杂交对发育异常的进展与消退和人乳头瘤病毒DNA存在之间关系的回顾性分析]

[Retrospective analysis of relationship between progression and regression of dysplasia and existence of HPV DNA by in situ hybridization].

作者信息

Ebisawa K, Shinozuka T, Kawai K, Fujii A, Kuroshima Y

机构信息

Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa.

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1994 Oct;46(10):1041-8.

PMID:7814934
Abstract

We investigated the relationship between the progression and regression of cervical dysplasia and the existence of HPV DNA. The materials we analyzed were 80 biopsied specimens obtained from 22 cases of dysplasia which were followed-up for a long time at our out-patient clinic, and 47 specimens of squamous cell carcinoma. Detection of HPV DNA was done by in situ hybridization with biotinylated HPV DNA probes types 6/11, 16/18 and 31/33/35. The analysis of several specimens obtained at long term follow-up showed that the dysplasia-progression group had a higher incidence and more frequent detection of HPV DNA than the regression group. In the progression group, HPV 16/18 were detected more frequently than HPV 31/33/35 at the dysplasia lesion, but HPV 6/11 was detected in neither the dysplasia nor the squamous cell carcinoma. Fourteen of the 47 cases of squamous cell carcinoma (29.8%) were positive for HPV DNA, and 13 of them (92.9%) were detected in the lesions of dysplasia adjacent to carcinoma in situ or invasive cancer. Comparison of the detection rate for HPV DNA was done in the 3 dysplastic areas, i.e. the dysplastic areas in the dysplasia progression group (A), dysplasia regression group (B) and in the area adjacent to squamous cell carcinoma (C). The detection rates for HPV DNA were 43.5% in A, 27.7% in C and 15.0% in B. From these results we drew the following conclusions: 1) The continuous existence of HPV DNA, especially type 16/18 in the dysplasia lesions, may progress from lesions to carcinoma in situ or invasive cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了宫颈发育异常的进展与消退和人乳头瘤病毒(HPV)DNA存在之间的关系。我们分析的材料包括从22例发育异常病例获取的80份活检标本,这些病例在我们门诊进行了长期随访,以及47份鳞状细胞癌标本。采用生物素化的HPV 6/11、16/18和31/33/35型DNA探针进行原位杂交检测HPV DNA。对长期随访获取的多个标本进行分析显示,发育异常进展组HPV DNA的发生率更高且检测更频繁,高于消退组。在进展组中,发育异常病变处HPV 16/18的检测频率高于HPV 31/33/35,但在发育异常或鳞状细胞癌中均未检测到HPV 6/11。47例鳞状细胞癌中有14例(29.8%)HPV DNA呈阳性,其中13例(92.9%)在原位癌或浸润癌相邻的发育异常病变中检测到。在3个发育异常区域,即发育异常进展组的发育异常区域(A)、发育异常消退组(B)以及鳞状细胞癌相邻区域(C),对HPV DNA的检测率进行了比较。HPV DNA的检测率在A组为43.5%,在C组为27.7%,在B组为15.0%。从这些结果我们得出以下结论:1)HPV DNA的持续存在,尤其是发育异常病变中的16/18型,可能使病变进展为原位癌或浸润癌。(摘要截短至250字)

相似文献

1
[Retrospective analysis of relationship between progression and regression of dysplasia and existence of HPV DNA by in situ hybridization].[通过原位杂交对发育异常的进展与消退和人乳头瘤病毒DNA存在之间关系的回顾性分析]
Nihon Sanka Fujinka Gakkai Zasshi. 1994 Oct;46(10):1041-8.
2
[Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].[人乳头瘤病毒(HPV)在子宫颈癌及相关病变中致癌作用的分子生物学研究——HPV16、18型E6/E7基因mRNA分析]
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Aug;42(8):823-33.
3
Detection of various types of human papillomaviruses in premalignant and malignant cervical lesions using DNA-DNA in situ hybridization.运用DNA-DNA原位杂交技术检测癌前及恶性宫颈病变中的多种人乳头瘤病毒类型。
J Med Assoc Thai. 1994 Mar;77(3):120-5.
4
[In situ hybridization study on the localization of HPV DNA in the precancerous lesions of uterine cervix].[子宫颈癌前病变中HPV DNA定位的原位杂交研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Mar;41(3):313-20.
5
Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.通过聚合酶链反应单链DNA构象多态性分析在宫颈发育异常中频繁检测到人乳头瘤病毒
Anticancer Res. 2002 May-Jun;22(3):1655-60.
6
[Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].[应用原位聚合酶链反应检测子宫颈不同病变中的人乳头瘤病毒DNA]
Rinsho Byori. 1997 Jan;45(1):82-6.
7
Simultaneous detection of antigens and specific DNA sequences of human papillomavirus in uterine cervical biopsy specimens. Description of a double-labelling technique.子宫颈活检标本中人乳头瘤病毒抗原和特定DNA序列的同步检测。一种双重标记技术的描述。
Eur J Histochem. 1997;41(4):255-9.
8
Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods.子宫颈疣状癌中人乳头瘤病毒的检测:免疫组织化学、原位杂交和原位聚合酶链反应方法的比较
Pathol Res Pract. 1998;194(10):713-20. doi: 10.1016/S0344-0338(98)80131-3.
9
[Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].[新疆维吾尔族女性宫颈鳞状细胞癌中人乳头瘤病毒DNA的检测]
Zhonghua Fu Chan Ke Za Zhi. 1997 Jul;32(7):405-8.
10
Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.通过聚合酶链反应检测子宫颈鳞状细胞癌和腺癌中的人乳头瘤病毒DNA。
Cancer. 1996 Jun 1;77(11):2275-9. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2275::AID-CNCR14>3.0.CO;2-U.